← All patents

US12590335B2

Targeted measure of transcriptional activity related to hormone receptors

University of Texas System

Abstract

Provided herein are methods of determining tumoral sensitivity to hormonal (endocrine) therapy based upon an index of estrogen receptor (ER)- and progesterone receptor (PR)-related genes, referred to as the sensitivity to endocrine therapy index (SET ER/PR index), and may have additional …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
William Fraser SYMMANS
Priority date
April 29, 2016
Filing date
June 21, 2023
Grant date
March 31, 2026
Publication date
March 31, 2026
Language
en
Metadata fetched
August 29, 2026 00:37